NCT03682289 2026-04-23Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid TumorsUniversity of California, San FranciscoPhase 2 Active not recruiting83 enrolled
NCT04065269 2026-02-20ATARIInstitute of Cancer Research, United KingdomPhase 2 Active not recruiting174 enrolled